SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-158429
Filing Date
2024-06-10
Accepted
2024-06-10 17:07:03
Documents
14
Period of Report
2024-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d750542d8ka.htm   iXBRL 8-K/A 26562
2 EX-10.1 d750542dex101.htm EX-10.1 73580
  Complete submission text file 0001193125-24-158429.txt   251122

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA svra-20240606.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20240606_lab.xml EX-101.LAB 18702
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20240606_pre.xml EX-101.PRE 11706
18 EXTRACTED XBRL INSTANCE DOCUMENT d750542d8ka_htm.xml XML 4433
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-32157 | Film No.: 241033692
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)